The Effect of Peripartum Magnesium Sulfate Use on the Occurrence of Postpartum Depression
NCT ID: NCT05751746
Last Updated: 2023-03-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
108 participants
OBSERVATIONAL
2023-01-30
2024-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Low-dose Ketamine and Postpartum Depression in Parturients With Prenatal Depression
NCT03336541
Low-dose S-ketamine in Women With Prenatal Depression
NCT04414943
EEG Alterations of Uterine Contractions in the First Stage of Labor Predicting Postpartum Depression
NCT05217251
Ketamine to Prevent PPD After Cesarean
NCT04227704
Impact of Giving Birth During the Covid 19 Pandemia on Postnatal Women's Depression
NCT04368208
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Control group with participants who do not get magnesium sulfate administration.
No interventions assigned to this group
Magnesium group
Intervention group with participants who get magnesium sulfate administration.
Magnesium sulfate
Magnesium sulfate will be administered following a protocol that obstetricians already use in our hospital.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Magnesium sulfate
Magnesium sulfate will be administered following a protocol that obstetricians already use in our hospital.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Gestational week \>= 30 week
* Singleton
Exclusion Criteria
18 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Bundang Hospital
Seongnam-si, Gyeonguido, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
B-2209-780-302
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.